Articles written by Dimitry Nakhla - Benzinga

Babylon Capital® Quality & Valuation Analysis On Hershey | Savor The Dividends & Indulge In Value

Following a peak valuation at 28x Earnings, The Hershey Company's (NYSE: HSY) stock has declined 31% over the past six months. I believe that HSY is currently undervalued, potentially offering investors appealing risk-adjusted returns and consistent annual dividend growth.

Babylon Capital® Quality & Valuation Analysis On PayPal | The Potential For A Significant Rebound Once The Narrative Flips

After reaching a peak of $310.16 on July 26, 2021, PayPal’s (NASDAQ: PYPL) stock has declined by about 80%.

Babylon Capital® Quality & Valuation Analysis On Visa | Why Visa May Be Poised For A Breakout After 2 Years Of Consolidation

Visa (NYSE: V) has been in consolidation for two years, since trading at an all-time high of $252.67 on July 27, 2021. This was warranted considering that V was trading 37x earnings, significantly higher than its typical range of 25x – 30x earnings.

Babylon Capital® Quality & Valuation Analysis On Inmode | Why Inmode Deserves To Be In Your Watchlist

Inmode (NASDAQ: INMD) is a company in the medical technology sector that focuses on creating and producing advanced medical devices for aesthetic and surgical procedures. INMD deserves to be in your watchlist because it’s an undervalued high-quality business with long-term potential.